Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier

Chemical Communications

Volumn 50, Issue 11, 2014, Pages 1323-1325

  Tang, Qiong ^a   Cao, Bin ^a   Cheng, Gang ^a  

^a The University of Akron   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DRUG CARRIER; SMALL INTERFERING RNA;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; DISULFIDES; DRUG CARRIERS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OLIGOPEPTIDES; PRODRUGS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84892145853     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c3cc47970f     Document Type: Article

References (26)

1. A. Persidis, Nat. Biotechnol., 1999:17, 94
2. M. M. Gottesman, T. Fojo, S. E. Bates, Nat. Rev. Cancer, 2002:2, 48
3. R. Krishna, L. D. Mayer, Eur. J. Pharm. Sci., 2000:11, 265
4. R. Tong, J. Cheng, Angew. Chem., Int. Ed., 2008:47, 4830
5. V. R. Caiolfa, M. Zamai, A. Fiorino, E. Frigerio, C. Pellizzoni, R. d’argy, A. Ghiglieri, M. G. Castelli, M. Farao, E. Pesenti, M. Gigli, F. Angelucci, A. Suarato, J. Controlled Release, 2000:65, 105
6. O. M. Koo, I. Rubinstein, H. Onyuksel, Nanomedicine, 2005:1, 77
7. R. B. Greenwald, Y. H. Choe, J. McGuire, C. D. Conover, Adv. Drug Delivery Rev., 2003:55, 217
8. Y. Q. Shen, E. L. Jin, B. Zhang, C. J. Murphy, M. H. Sui, J. Zhao, J. Q. Wang, J. B. Tang, M. H. Fan, E. Van Kirk, W. J. Murdoch, J. Am. Chem. Soc., 2010:132, 4259
9. R. Duncan, Nat. Rev. Cancer, 2006:6, 688
10. H. Wu, W. N. Hait, J. M. Yang, Cancer Res., 2003:63, 1515
11. Z. Wu, X. B. Li, Y. Y. Zeng, X. M. Zhuang, H. Shen, H. Q. Zhu, H. Y. Liu, H. Xiao, Basic Clin. Pharmacol. Toxicol., 2011:108, 177
12. R. T. Lima, S. M. Martins, J. E. Guimaraes, C. Sambade, M. H. Vasconcelos, Cancer Gene Ther., 2004:11, 309
13. M. Saad, O. B. Garbuzenko, T. Minko, Nanomedicine, 2008:3, 761-776
14. A. M. Chen, M. Zhang, D. G. Wei, D. Stueber, O. Taratula, T. Minko, H. X. He, Small, 2009:5, 2673
15. X. B. Xiong, A. Lavasanifar, ACS Nano, 2011:5, 5202
16. A. de Fougerolles, H. P. Vornlocher, J. Maraganore, J. Lieberman, Nat. Rev. Drug Discovery, 2007:6, 443
17. J. Wang, Z. Lu, M. G. Wientjes, J. L. S. Au, AAPS J., 2010:12, 492
18. P. Parhi, C. Mohanty, S. K. Sahoo, Drug Discovery Today, 2012:17, 1044
19. Q. Tang, B. Cao, H. Y. Wu, G. Cheng, PLoS One, 2013, 8
20. S. Bauhuber, C. Hozsa, M. Breunig, A. Gopferich, Adv. Mater., 2009:21, 3286
21. T. Ito, L. Sun, M. A. Bevan, R. M. Crooks, Langmuir, 2004:20, 6940-6945
22. W. Jiang, B. Y. S. Kim, J. T. Rutka, W. C. W. Chan, Nat. Nanotechnol., 2008:3, 145
23. S. D. Perrault, C. Walkey, T. Jennings, H. C. Fischer, W. C. W. Chan, Nano Lett., 2009:9, 1909
24. N. Wiradharma, M. Khan, Y. W. Tong, S. Wang, Y.-Y. Yang, Adv. Funct. Mater., 2008:18, 943
25. Y. L. Chiu, A. Ali, C. Y. Chu, H. Cao, T. M. Rana, Chem. Biol., 2004:11, 1165
26. S. E. Martin, Z. H. Wu, K. Gehlhaus, T. L. Jones, Y. W. Zhang, R. Guha, S. Miyamoto, Y. Pommier, N. J. Caplen, Curr. Cancer Drug Targets, 2011:11, 976